Previous close | 2.3900 |
Open | 2.4500 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 2.3000 - 2.4500 |
52-week range | 1.1800 - 6.1000 |
Volume | |
Avg. volume | 13,813 |
Market cap | 42.332M |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 119.50 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 04 July 2022 |
1y target est | N/A |
BLANQUEFORT, France, May 03, 2024--Regulatory News: Groupe Berkem (Paris:ALKEM):
BLANQUEFORT, France, April 30, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), announces its full-year financial results for the year ended December 31, 2023, as approved by its Board of Directors on April 26, 2024. The audit procedures on the full-year accounts have been conducted and the auditors' report is being issued. The Company also reports on its 2024 first-quarter revenue.
BLANQUEFORT, France, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), today announces its consolidated 2023 full-year revenue, as at December 31, 2023.